Idera Pharma (IDRA) Files $75M Mixed Shelf
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) filed a registration with the U.S. SEC to sell, from time to time, up to $75 million of Common Stock, Preferred Stock, Depositary Shares, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Market Wrap: Chinese Stock Pressure Hits U.S. Markets; Durable Orders Outpace in June; Merger Monday
- Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
- National Security Group (NSEC) Declares $0.04 Quarterly Dividend; 1.1% Yield
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!